• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The Difference of Treatment Results between Botulinum Toxin A Split Injection Sites and Botulinum Toxin A Non-Split Injection Sites for Hemifacial Spasm.

作者信息

Prutthipongsit Anuwat, Aui-aree Nipat

出版信息

J Med Assoc Thai. 2015 Nov;98(11):1119-23.

PMID:26817183
Abstract

OBJECTIVE

To compare hemifacial spasm treatment results between Botulinum toxin A split injection sites and Botulinum toxin A non-split injection sites.

MATERIAL AND METHOD

Thirty-one hemifacial spasm patients were randomly assigned into the non-split injection sites group (injecting Botulinum toxin A to the zygomaticus major and risorius each) or split injection sites group with the same amount of Botulinum toxin A as the first method (injection Botulinum toxin A to the zygomaticus major and minor and risorius two injections each) The main outcomes are onset of improvement and effective duration of treatment.

RESULTS

Fifteen patients were assigned to non-split injection sites group and 16 patients were assigned to split injection sites group. The median onset of improvement in non-split injection sites group and split injection sites group was 4.0 and 4.5 days, respectively (p = 0.984). The effective duration of treatment in the non-split injection sites group was 60.0 days and in the split injection sites group was 54.5 days (p = 0.582).

CONCLUSION

The splitting of injection sites did not signicantly improve the efficacy of Botulinum toxin A in the treatment of hemifacial spasm.

摘要

相似文献

1
The Difference of Treatment Results between Botulinum Toxin A Split Injection Sites and Botulinum Toxin A Non-Split Injection Sites for Hemifacial Spasm.
J Med Assoc Thai. 2015 Nov;98(11):1119-23.
2
Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.A型肉毒杆菌毒素注射治疗眼睑痉挛和半面痉挛的长期疗效及安全性。
Clin Exp Ophthalmol. 2014 Apr;42(3):254-61. doi: 10.1111/ceo.12165. Epub 2013 Aug 4.
3
Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.A型肉毒毒素治疗后偏侧面肌痉挛患者的生活质量;Dysport和Neuronox的24周双盲随机交叉对照研究
J Med Assoc Thai. 2012 Mar;95 Suppl 3:S48-54.
4
Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.卡马西平联合A型肉毒毒素治疗眼睑痉挛和半面痉挛的疗效
Eye Sci. 2012 Dec;27(4):178-81. doi: 10.3969/j.issn.1000-4432.2012.04.005.
5
Hemifacial spasm: results of treatment with low dose botulinum toxin injection.半面痉挛:低剂量肉毒杆菌毒素注射治疗的结果
J Med Assoc Thai. 2004 Oct;87(10):1205-11.
6
[Safety and efficacy of botulinum toxin in hemifacial spasm].肉毒杆菌毒素治疗面肌痉挛的安全性与有效性
J Fr Ophtalmol. 2013 Mar;36(3):242-6. doi: 10.1016/j.jfo.2012.01.011. Epub 2012 Dec 25.
7
Decompression Surgery in Elderly Patients with Hemifacial Spasm Refractory to Botulinum Toxin.老年面肌痉挛患者肉毒毒素治疗抵抗后的减压手术
Mov Disord Clin Pract. 2024 Aug;11(8):966-972. doi: 10.1002/mdc3.14064. Epub 2024 May 23.
8
Local injection of botulinum toxin type A for hemifacial spasm.局部注射A型肉毒杆菌毒素治疗面肌痉挛。
Neurol Med Chir (Tokyo). 2002 Jun;42(6):245-8; discussion 248-9. doi: 10.2176/nmc.42.245.
9
Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.肉毒杆菌毒素注射治疗面肌痉挛16年。
J Clin Neurosci. 2015 Aug;22(8):1319-25. doi: 10.1016/j.jocn.2015.02.032. Epub 2015 Jun 19.
10
[Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].[原发性睑痉挛和半面痉挛:患者特征、A型肉毒杆菌毒素治疗及文献综述]
Arq Bras Oftalmol. 2006 Jan-Feb;69(1):23-6. doi: 10.1590/s0004-27492006000100005. Epub 2006 Feb 10.

引用本文的文献

1
Botulinum Toxin in Movement Disorders: An Update.肉毒毒素在运动障碍中的应用:最新进展。
Toxins (Basel). 2021 Jan 8;13(1):42. doi: 10.3390/toxins13010042.